| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 26 | 2025 | 211 | 4.810 |
Why?
|
| Calcium | 24 | 2025 | 339 | 2.990 |
Why?
|
| Mitochondrial Proteins | 11 | 2025 | 72 | 2.720 |
Why?
|
| Calcium Channels | 12 | 2025 | 63 | 2.460 |
Why?
|
| Calcium Signaling | 8 | 2025 | 49 | 1.910 |
Why?
|
| Mitochondrial Membranes | 6 | 2024 | 27 | 1.870 |
Why?
|
| Myocytes, Cardiac | 15 | 2024 | 90 | 1.430 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2015 | 64 | 1.360 |
Why?
|
| Membrane Proteins | 7 | 2025 | 243 | 1.210 |
Why?
|
| DNA-Binding Proteins | 3 | 2014 | 149 | 1.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2020 | 69 | 1.110 |
Why?
|
| Signal Transduction | 10 | 2024 | 727 | 1.110 |
Why?
|
| Autophagy | 8 | 2020 | 55 | 1.020 |
Why?
|
| Apoptosis | 8 | 2025 | 375 | 1.000 |
Why?
|
| NF-kappa B | 4 | 2019 | 84 | 0.970 |
Why?
|
| Carrier Proteins | 4 | 2018 | 145 | 0.970 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2025 | 38 | 0.960 |
Why?
|
| Ubiquitination | 3 | 2015 | 15 | 0.950 |
Why?
|
| Animals | 36 | 2025 | 8199 | 0.870 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2015 | 215 | 0.870 |
Why?
|
| Energy Metabolism | 7 | 2020 | 153 | 0.850 |
Why?
|
| Proteomics | 2 | 2023 | 97 | 0.840 |
Why?
|
| I-kappa B Kinase | 2 | 2014 | 7 | 0.810 |
Why?
|
| Mice | 23 | 2025 | 2571 | 0.760 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 6 | 2023 | 10 | 0.750 |
Why?
|
| Cell Nucleus | 3 | 2020 | 111 | 0.720 |
Why?
|
| Reactive Oxygen Species | 11 | 2024 | 163 | 0.710 |
Why?
|
| MicroRNAs | 6 | 2025 | 181 | 0.690 |
Why?
|
| Metabolome | 1 | 2020 | 37 | 0.640 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 42 | 0.630 |
Why?
|
| Mice, Knockout | 12 | 2023 | 454 | 0.630 |
Why?
|
| Mitochondria, Heart | 5 | 2024 | 17 | 0.630 |
Why?
|
| Humans | 44 | 2025 | 32284 | 0.610 |
Why?
|
| Oxidative Stress | 7 | 2020 | 255 | 0.600 |
Why?
|
| Membrane Potential, Mitochondrial | 9 | 2025 | 20 | 0.600 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 108 | 0.560 |
Why?
|
| Hepatocytes | 1 | 2019 | 80 | 0.560 |
Why?
|
| Endothelial Cells | 4 | 2024 | 193 | 0.560 |
Why?
|
| Cardiomyopathies | 4 | 2020 | 67 | 0.550 |
Why?
|
| Hela Cells | 9 | 2019 | 72 | 0.510 |
Why?
|
| Heart Failure | 6 | 2023 | 728 | 0.500 |
Why?
|
| Nerve Tissue Proteins | 2 | 2018 | 124 | 0.490 |
Why?
|
| Stress, Physiological | 2 | 2018 | 56 | 0.480 |
Why?
|
| Apoptosis Regulatory Proteins | 5 | 2020 | 38 | 0.470 |
Why?
|
| Oxidants | 1 | 2015 | 15 | 0.470 |
Why?
|
| Endoplasmic Reticulum | 2 | 2014 | 24 | 0.460 |
Why?
|
| Hydrogen Peroxide | 1 | 2015 | 85 | 0.450 |
Why?
|
| Gene Expression Regulation | 8 | 2025 | 478 | 0.430 |
Why?
|
| Caspase 8 | 2 | 2015 | 9 | 0.430 |
Why?
|
| Multigene Family | 1 | 2014 | 50 | 0.430 |
Why?
|
| Cell Line, Tumor | 8 | 2025 | 729 | 0.420 |
Why?
|
| Sodium-Calcium Exchanger | 3 | 2025 | 6 | 0.410 |
Why?
|
| Calcium-Binding Proteins | 4 | 2023 | 48 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 792 | 0.410 |
Why?
|
| Phagosomes | 1 | 2013 | 6 | 0.400 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2024 | 9 | 0.360 |
Why?
|
| Protein Kinases | 2 | 2024 | 34 | 0.360 |
Why?
|
| Myocardial Ischemia | 2 | 2024 | 98 | 0.340 |
Why?
|
| Oxidative Phosphorylation | 4 | 2025 | 30 | 0.340 |
Why?
|
| Cardiomegaly | 3 | 2019 | 29 | 0.320 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2020 | 4 | 0.300 |
Why?
|
| Alzheimer Disease | 2 | 2025 | 280 | 0.300 |
Why?
|
| Cell Line | 6 | 2025 | 454 | 0.300 |
Why?
|
| Pulmonary Emphysema | 2 | 2019 | 23 | 0.300 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2018 | 17 | 0.290 |
Why?
|
| Ion Channel Gating | 2 | 2020 | 20 | 0.290 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 466 | 0.290 |
Why?
|
| Ubiquitin | 2 | 2020 | 15 | 0.280 |
Why?
|
| Cell Hypoxia | 3 | 2024 | 43 | 0.270 |
Why?
|
| Unfolded Protein Response | 2 | 2020 | 15 | 0.260 |
Why?
|
| Protein Transport | 4 | 2019 | 80 | 0.260 |
Why?
|
| Cell Movement | 4 | 2016 | 167 | 0.250 |
Why?
|
| Sepsis | 2 | 2019 | 164 | 0.250 |
Why?
|
| GTP Phosphohydrolases | 1 | 2025 | 7 | 0.230 |
Why?
|
| Mitochondria, Muscle | 1 | 2025 | 18 | 0.220 |
Why?
|
| Enzyme Activation | 3 | 2015 | 138 | 0.220 |
Why?
|
| Myocardial Contraction | 6 | 2020 | 59 | 0.220 |
Why?
|
| Ribosomal Proteins | 1 | 2024 | 5 | 0.210 |
Why?
|
| Nuclear Proteins | 1 | 2024 | 74 | 0.210 |
Why?
|
| Cell Cycle Proteins | 1 | 2024 | 52 | 0.210 |
Why?
|
| DNA Damage | 3 | 2019 | 90 | 0.210 |
Why?
|
| Parkinson Disease | 1 | 2025 | 87 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 83 | 0.200 |
Why?
|
| Caspase 3 | 2 | 2025 | 38 | 0.190 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 1083 | 0.190 |
Why?
|
| Adenosine Triphosphate | 5 | 2024 | 71 | 0.190 |
Why?
|
| Pulmonary Alveoli | 2 | 2019 | 20 | 0.190 |
Why?
|
| Cells, Cultured | 3 | 2019 | 839 | 0.190 |
Why?
|
| Muscular Diseases | 1 | 2022 | 23 | 0.180 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 109 | 0.180 |
Why?
|
| Cation Transport Proteins | 2 | 2019 | 22 | 0.180 |
Why?
|
| Blotting, Western | 3 | 2018 | 299 | 0.170 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2020 | 5 | 0.170 |
Why?
|
| Melanoma | 1 | 2022 | 166 | 0.170 |
Why?
|
| Proline | 1 | 2020 | 11 | 0.160 |
Why?
|
| JC Virus | 1 | 2020 | 20 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 520 | 0.160 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 24 | 0.160 |
Why?
|
| Disease Progression | 2 | 2019 | 591 | 0.160 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 11 | 0.160 |
Why?
|
| Substrate Specificity | 1 | 2020 | 80 | 0.160 |
Why?
|
| Protein Folding | 1 | 2020 | 31 | 0.160 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 23 | 0.160 |
Why?
|
| Cell Differentiation | 2 | 2019 | 461 | 0.160 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 12 | 0.160 |
Why?
|
| Heart Ventricles | 2 | 2018 | 146 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 16 | 0.150 |
Why?
|
| Calgranulin A | 1 | 2019 | 2 | 0.150 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2019 | 19 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 65 | 0.150 |
Why?
|
| Interleukin-8 | 1 | 2019 | 22 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 81 | 0.150 |
Why?
|
| Hyperglycemia | 1 | 2020 | 85 | 0.150 |
Why?
|
| Female | 10 | 2025 | 19947 | 0.150 |
Why?
|
| Calcium Channels, L-Type | 2 | 2018 | 46 | 0.150 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2019 | 9 | 0.150 |
Why?
|
| Mitochondria, Liver | 1 | 2019 | 6 | 0.150 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 24 | 0.150 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 90 | 0.150 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 762 | 0.150 |
Why?
|
| Mutation | 2 | 2018 | 497 | 0.150 |
Why?
|
| Zebrafish | 1 | 2019 | 23 | 0.150 |
Why?
|
| Butylene Glycols | 1 | 2019 | 1 | 0.150 |
Why?
|
| Glucosides | 1 | 2019 | 13 | 0.150 |
Why?
|
| Aging | 1 | 2025 | 942 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2015 | 603 | 0.140 |
Why?
|
| Protein Binding | 2 | 2016 | 244 | 0.140 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 23 | 0.140 |
Why?
|
| HIV-1 | 1 | 2018 | 46 | 0.140 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2018 | 12 | 0.140 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2018 | 10 | 0.140 |
Why?
|
| Cyanides | 1 | 2018 | 2 | 0.140 |
Why?
|
| Methylene Blue | 1 | 2018 | 3 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 33 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 246 | 0.140 |
Why?
|
| Lysosomes | 2 | 2018 | 10 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 78 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 89 | 0.130 |
Why?
|
| Male | 8 | 2025 | 19443 | 0.130 |
Why?
|
| Cell-Derived Microparticles | 1 | 2017 | 4 | 0.130 |
Why?
|
| Nicotine | 1 | 2019 | 164 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 19 | 0.130 |
Why?
|
| Blood Platelets | 1 | 2017 | 59 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2018 | 168 | 0.130 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 70 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2015 | 499 | 0.120 |
Why?
|
| Magnesium | 1 | 2016 | 29 | 0.120 |
Why?
|
| Ventricular Remodeling | 3 | 2023 | 63 | 0.120 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2016 | 5 | 0.120 |
Why?
|
| Melanins | 1 | 2016 | 7 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2016 | 66 | 0.120 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2016 | 8 | 0.120 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2016 | 17 | 0.120 |
Why?
|
| Cytochromes c | 1 | 2015 | 3 | 0.120 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 33 | 0.120 |
Why?
|
| Cyclophilins | 1 | 2015 | 1 | 0.120 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2015 | 2 | 0.120 |
Why?
|
| Metalloendopeptidases | 1 | 2015 | 10 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 1437 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 95 | 0.120 |
Why?
|
| African Americans | 2 | 2020 | 1335 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 114 | 0.120 |
Why?
|
| Heart Conduction System | 1 | 2016 | 76 | 0.110 |
Why?
|
| Heart Atria | 1 | 2016 | 81 | 0.110 |
Why?
|
| Homeostasis | 3 | 2022 | 130 | 0.110 |
Why?
|
| Heart | 1 | 2016 | 177 | 0.110 |
Why?
|
| Isoproterenol | 3 | 2020 | 17 | 0.110 |
Why?
|
| Myocardium | 3 | 2019 | 184 | 0.100 |
Why?
|
| Tunicamycin | 1 | 2013 | 6 | 0.100 |
Why?
|
| Oxidation-Reduction | 3 | 2020 | 274 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 423 | 0.100 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2012 | 2 | 0.100 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 13 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 14 | 0.100 |
Why?
|
| HIV Infections | 1 | 2018 | 450 | 0.100 |
Why?
|
| Cytoplasm | 1 | 2012 | 29 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2012 | 45 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2013 | 183 | 0.090 |
Why?
|
| Leucyl Aminopeptidase | 1 | 2012 | 1 | 0.090 |
Why?
|
| Biofilms | 1 | 2012 | 22 | 0.090 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2011 | 12 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 55 | 0.090 |
Why?
|
| Cell Survival | 3 | 2018 | 288 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 120 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2012 | 93 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 410 | 0.090 |
Why?
|
| Rotenone | 2 | 2025 | 4 | 0.080 |
Why?
|
| Adrenergic Agents | 2 | 2020 | 7 | 0.080 |
Why?
|
| Superoxides | 2 | 2019 | 24 | 0.080 |
Why?
|
| Smoke | 2 | 2019 | 13 | 0.080 |
Why?
|
| Fibrosis | 2 | 2019 | 126 | 0.070 |
Why?
|
| Antioxidants | 2 | 2020 | 122 | 0.070 |
Why?
|
| Oxygen Consumption | 2 | 2019 | 141 | 0.070 |
Why?
|
| Neoplasms | 1 | 2015 | 754 | 0.070 |
Why?
|
| Ventricular Function, Left | 2 | 2019 | 264 | 0.060 |
Why?
|
| Excitation Contraction Coupling | 2 | 2018 | 8 | 0.060 |
Why?
|
| Membrane Potentials | 2 | 2018 | 76 | 0.060 |
Why?
|
| RNA Interference | 2 | 2018 | 78 | 0.060 |
Why?
|
| Lipopolysaccharides | 2 | 2017 | 121 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2018 | 193 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 2019 | 32 | 0.060 |
Why?
|
| Cell Death | 2 | 2017 | 79 | 0.060 |
Why?
|
| Aged | 3 | 2025 | 10265 | 0.060 |
Why?
|
| Action Potentials | 2 | 2018 | 212 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2018 | 100 | 0.060 |
Why?
|
| Astrocytes | 1 | 2025 | 61 | 0.060 |
Why?
|
| Oxidopamine | 1 | 2025 | 24 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2017 | 285 | 0.060 |
Why?
|
| Middle Aged | 3 | 2025 | 11853 | 0.060 |
Why?
|
| Microglia | 1 | 2025 | 67 | 0.060 |
Why?
|
| Sarcopenia | 1 | 2025 | 50 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2024 | 24 | 0.050 |
Why?
|
| Atrial Appendage | 1 | 2024 | 24 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2024 | 100 | 0.050 |
Why?
|
| Ischemia | 1 | 2024 | 115 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 74 | 0.050 |
Why?
|
| Glucose | 1 | 2022 | 160 | 0.040 |
Why?
|
| Cholesterol | 1 | 2022 | 262 | 0.040 |
Why?
|
| Dimerization | 1 | 2020 | 30 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2020 | 20 | 0.040 |
Why?
|
| Genes, Fungal | 1 | 2020 | 4 | 0.040 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2020 | 5 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 17 | 0.040 |
Why?
|
| Virus Replication | 1 | 2020 | 42 | 0.040 |
Why?
|
| Exercise | 1 | 2025 | 603 | 0.040 |
Why?
|
| Phosphotransferases | 1 | 2020 | 4 | 0.040 |
Why?
|
| Ketoglutaric Acids | 1 | 2019 | 5 | 0.040 |
Why?
|
| Glycolysis | 1 | 2019 | 17 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 16 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 31 | 0.040 |
Why?
|
| Cytoprotection | 1 | 2019 | 9 | 0.040 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2019 | 18 | 0.040 |
Why?
|
| Aerosols | 1 | 2019 | 15 | 0.040 |
Why?
|
| Neuroblastoma | 1 | 2019 | 32 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 79 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2019 | 119 | 0.040 |
Why?
|
| Cecum | 1 | 2019 | 10 | 0.040 |
Why?
|
| Diabetic Angiopathies | 1 | 2020 | 150 | 0.040 |
Why?
|
| Punctures | 1 | 2019 | 32 | 0.040 |
Why?
|
| Ligation | 1 | 2019 | 64 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2020 | 171 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 144 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 132 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2018 | 27 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 17 | 0.030 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2018 | 2 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 96 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 49 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 315 | 0.030 |
Why?
|
| Ion Channels | 1 | 2018 | 26 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 111 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 257 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2018 | 131 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 237 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 3902 | 0.030 |
Why?
|
| Receptors, Proteinase-Activated | 1 | 2017 | 1 | 0.030 |
Why?
|
| NADH Dehydrogenase | 1 | 2017 | 4 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 477 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 203 | 0.030 |
Why?
|
| COS Cells | 1 | 2017 | 33 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2017 | 22 | 0.030 |
Why?
|
| Thrombin | 1 | 2017 | 25 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2017 | 25 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 87 | 0.030 |
Why?
|
| Glutathione | 1 | 2017 | 54 | 0.030 |
Why?
|
| Cations, Divalent | 1 | 2016 | 4 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 204 | 0.030 |
Why?
|
| Echocardiography | 1 | 2017 | 190 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2016 | 110 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 854 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 146 | 0.030 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2016 | 2 | 0.030 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2016 | 5 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 222 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 622 | 0.030 |
Why?
|
| Sarcolemma | 1 | 2016 | 4 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 204 | 0.030 |
Why?
|
| Cysteine | 1 | 2017 | 145 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 955 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2016 | 99 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2016 | 54 | 0.030 |
Why?
|
| Neurons | 1 | 2019 | 486 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 112 | 0.030 |
Why?
|
| Binding Sites | 1 | 2015 | 144 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 821 | 0.030 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2015 | 8 | 0.030 |
Why?
|
| Clone Cells | 1 | 2015 | 35 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 1534 | 0.030 |
Why?
|
| Caspases | 1 | 2013 | 41 | 0.030 |
Why?
|
| Rats | 1 | 2018 | 1895 | 0.030 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2012 | 1 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2012 | 19 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 15 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 965 | 0.020 |
Why?
|
| Genome | 1 | 2012 | 38 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 28 | 0.020 |
Why?
|
| Adult | 1 | 2025 | 9259 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 258 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 26 | 0.020 |
Why?
|
| Leucine | 1 | 2012 | 23 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2012 | 74 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 545 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 67 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 2205 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 250 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 290 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 359 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 324 | 0.020 |
Why?
|